Year,ESBL,ESBL,CRE,CRE,Consumption cephalosporins,Consumption cephalosporins,Consumption carbapenems,Consumption carbapenems,,,
,"Number of isolates, ESBL",Prevalence of ESBL,"Number of isolates, CRE",Prevalence of CRE,Community,Hospital,Community,Hospital,,,
2006,311,87,300,1,0.47,0.105,0,0.016,,,
2007,301,61,285,2,0.36,0.1061,0,0.016,,,
2008,317,81,309,0,0.38,0.1091,0,0.022,,,
2009,369,129,360,0,0.39,0.1143,0,0.022,,,
2010,359,138,360,2,0.39,0.1251,0,0.026,,,
2011,512,235,491,29,0.37,0.1308,0,0.027,,,
2012,431,230,413,10,0.3401,0.1416,0,0.032,,,
2013,500,216,481,18,0.35,0.1439,0,0.037,,,
2014,557,214,531,10,0.26,0.1476,0,0.042,,,
2015,644,231,621,10,0.21,0.156,0,0.046,,,
,704,263,687,6,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
Hospital size,720,,,,,,,,,,
Hospital stay,9.3,,,,,,,,,,
,,,,,,,,,,,
Cephalosporins community,3rd gen,4th gen,Sum,Cephalosporins hospital,3rd gen,4th gen,Sum,Carbapenems community,,Carbapenems hospital,
2006,0.47,0,0.47,2006,0.102,0.003,0.105,2006,0,2006,0.016
2007,0.36,0,0.36,2007,0.104,0.0021,0.1061,2007,0,2007,0.016
2008,0.38,0,0.38,2008,0.107,0.0021,0.1091,2008,0,2008,0.022
2009,0.39,0,0.39,2009,0.112,0.0023,0.1143,2009,0,2009,0.022
2010,0.39,0,0.39,2010,0.123,0.0021,0.1251,2010,0,2010,0.026
2011,0.37,0,0.37,2011,0.129,0.0018,0.1308,2011,0,2011,0.027
2012,0.34,0.0001,0.3401,2012,0.14,0.0016,0.1416,2012,0,2012,0.032
2013,0.35,0,0.35,2013,0.142,0.0019,0.1439,2013,0,2013,0.037
2014,0.26,0,0.26,2014,0.146,0.0016,0.1476,2014,0,2014,0.042
2015,0.21,0,0.21,2015,0.154,0.002,0.156,2015,0,2015,0.046